Boston Probes' Micro Dx Probe in a FISH assay Molecular biologists who happen upon the Boston Probes Web site might grin at what seems, at first glance, to be an apparent typo. "Partner with the Leader in PNA Technology," the site announces conspicuously. But there is no mistake. PNA (peptide nucleic acid) molecules are exciting and widely studied synthetic compounds with unique qualities and broad potential applications. With the recent release of its first commercial products, Boston Probes I
 Boston Probes' Micro Dx Probe in a FISH assay |
PNA, as its name implies, is a DNA mimic whose backbone is composed of repeating N-2-aminoethyl glycine units linked by amide bonds instead of the sugar-phosphate backbone of DNA. This unique structure lends impressive qualities. Though able to form base pairs normally, PNA is ...
When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.
